COX2 and p53 risk-alleles coexist in COPD

Clinica Chimica Acta

Volumn 397, Issue 1-2, 2008, Pages 48-50

  Arif, Ehtesham ^a,c   Vibhuti, Arpana ^a   Deepak, Desh ^b   Singh, Bhawani ^b   Siddiqui, Mohd Saeed ^c   Pasha, M A Qadar ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Chronic obstructive pulmonary disease; Cyclooxygenase; Gene polymorphisms; p53

Indexed keywords

ARGININE; CYCLOOXYGENASE 2; PROLINE; PROTEIN P53;

ALLELISM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; CYCLOOXYGENASE 2; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 51249121330     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.07.010     Document Type: Article

References (14)

1. Barnes P.J. Chronic obstructive pulmonary disease. N Engl J Med 343 (2000) 269-280
2. Taha R., Olivenstein R., Utsumi T., et al. Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 636-640
3. Anto R.J., Mukhopadhyay A., Shishodia S., Gairola C.G., and Aggarwal B.B. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB (alpha), correlation with induction of cyclooxygenase-2. Carcinogenesis 23 (2002) 1511-1518
4. Franklin W.A., Gazdar A.F., Haney J., et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 100 (1997) 2133-2137
5. Harris C.C. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88 (1996) 1442-1455
6. Han J.A., Kim J.I., Ongusaha P.P., et al. p53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J 21 (2002) 5635-5644
7. Arif E., Vibhuti A., Alam P., et al. Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease. Clin Chim Acta 328 (2007) 37-42
8. Sanak M., Szczeklik W., and Szczeklik A. Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma. J Allergy Clin Immunol 116 (2005) 221-223
9. Liu G., Miller D.P., Zhou W., et al. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res 61 (2001) 8718-8722
10. Montuschi P., Kharitonov S.A., Ciabattoni G., and Barnes P.J. Exhaled leukotrienes and prostaglandins in COPD. Thorax 58 (2003) 585-588
11. Dumont P., Leu J., Pietra III A.D., George D.L., and Murphy M. The codon72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33 (2003) 357-365
12. Arif E., Ahsan A., Vibhuti A., et al. Endothelial nitric oxide synthase gene variants contribute to oxidative stress in COPD. Biochem Biophys Res Commun 361 (2007) 182-188
13. Ahsan A., Ram R., and Baig MA Pasha M.A. ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clin Biochem 37 (2004) 1037-1040
14. Cok S.J., and Morrison A.R. The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem 276 (2001) 23179-23185